Filing Details

Accession Number:
0001078782-17-001160
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-17 16:08:34
Reporting Period:
2017-08-16
Filing Date:
2017-08-17
Accepted Time:
2017-08-17 16:08:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
93314 Volitionrx Ltd VNRX In Vitro & In Vivo Diagnostic Substances (2835) 911949078
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1340610 John Cameron Reynolds 1 Scotts Rd #24-05 Shaw Centre
Singapore U0 228208
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-16 3,630 $2.77 1,007,718 No 4 P Indirect Concord International, Inc.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Concord International, Inc.
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 34,076 Indirect By Wife
Common Stock 1,114,673 Direct
Footnotes
  1. The shares of Common Stock are held directly by Concord International, Inc. Mr. Reynolds is the majority shareholder of Concord International, Inc. and shares voting and dispositive control over the shares of Common Stock held by Concord International, Inc.